Advertisement
U.S. markets closed

DBV Technologies S.A. (DBV.PA)

Paris - Paris Delayed Price. Currency in EUR
0.6200-0.0340 (-5.20%)
At close: 05:35PM CET
Full screen
Loading interactive chart...
  • GlobeNewswire

    DBV Technologies Announces Plan to Implement ADS Ratio Change

    Châtillon, France, November 11, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J200), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares (the “ADS Ratio”), nominal value

  • Pharmaceutical Technology

    DBV Technologies’ stock slides as financial woes worsens

    The company reported that it does not have sufficient cash reserves to operate for the next 12 months and can only fund operations into Q1 2025.